Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: Role of D-alanine racemase

被引:58
作者
Halouska, Steven [1 ]
Chacon, Ofelia [2 ,3 ]
Fenton, Robert J. [2 ]
Zinniel, Denise K. [2 ]
Barletta, Raul G. [2 ]
Powers, Robert [1 ]
机构
[1] Univ Nebraska, Dept Chem, Lincoln, NE 68522 USA
[2] Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68522 USA
[3] Corp Invest Biol, Medellin, Colombia
关键词
NMR; principal component analysis; metabolomics; tuberculosis; D-cycloserine; Mycobacterium smegmatis; D-alanine racemase;
D O I
10.1021/pr0704332
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
D-Cycloserine (DCS) is only used with multidrug-resistant strains of tuberculosis because of serious side effects. DCS is known to inhibit cell wall biosynthesis, but the in vivo lethal target is still unknown. We have applied NMR-based metabolomics combined with principal component analysis to monitor the in vivo effect of DCS on Mycobacterium smegmatis. Our analysis suggests DCS functions by inhibiting multiple protein targets.
引用
收藏
页码:4608 / 4614
页数:7
相关论文
共 51 条
[1]  
[Anonymous], 2007, WHO REP 2007 GLOB TU
[2]  
Barry III C.E, 2003, ISSUES INFECT DIS, V2, P137
[3]  
BERBERICH R, 1968, J BIOL CHEM, V243, P1006
[4]   NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition [J].
Bollard, ME ;
Stanley, EG ;
Lindon, JC ;
Nicholson, JK ;
Holmes, E .
NMR IN BIOMEDICINE, 2005, 18 (03) :143-162
[5]   Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis [J].
Caceres, NE ;
Harris, NB ;
Wellehan, JF ;
Feng, ZY ;
Kapur, V ;
Barletta, RG .
JOURNAL OF BACTERIOLOGY, 1997, 179 (16) :5046-5055
[6]   Mycobacterium smegmatis D-alanine racemase mutants are not dependent on D-alanine for growth [J].
Chacon, O ;
Feng, ZY ;
Harris, NB ;
Cáceres, NE ;
Adams, LG ;
Barletta, RG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :47-54
[7]  
DAVID HL, 1969, AM REV RESPIR DIS, V100, P579
[8]  
Denessiouk KA, 1999, PROTEINS, V35, P250, DOI 10.1002/(SICI)1097-0134(19990501)35:2<250::AID-PROT10>3.0.CO
[9]  
2-X
[10]   MULTIDRUG-RESISTANT TUBERCULOSIS [J].
DOOLEY, SW ;
JARVIS, WR ;
MARTONE, WJ ;
SNIDER, DE .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :257-259